The emerging role of serum/glucocorticoid-regulated kinases in cancer

by Castel, Pau, Scaltriti, Maurizio
Published in Cell Cycle (2016)

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

by Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José
Published in Clin Cancer Res (2016)

NTRK fusion-positive cancers and TRK inhibitor therapy

by Cocco, Emiliano, Scaltriti, Maurizio, Drilon, Alexander
Published in Nat Rev Clin Oncol (2018)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

by Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Published 2011

A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer

by Gómez Tejeda Zañudo, Jorge, Scaltriti, Maurizio, Albert, Réka
Published in Cancer Converg (2017)

Quantification of HER family receptors in breast cancer

by Nuciforo, Paolo, Radosevic-Robin, Nina, Ng, Tony, Scaltriti, Maurizio
Published in Breast Cancer Res (2015)

Prevalence and role of HER2 mutations in cancer

by Cocco, Emiliano, Lopez, Salvatore, Santin, Alessandro D., Scaltriti, Maurizio
Published in Pharmacol Ther (2019)

AKT signaling in ERBB2-amplified breast cancer

by Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Published in Pharmacol Ther (2015)

Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment

by Castel, Pau, Toska, Eneda, Zumsteg, Zachary S, Carmona, F Javier, Elkabets, Moshe, Bosch, Ana, Scaltriti, Maurizio
Published in Mol Cell Oncol (2014)

Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin

by Caccamo, Alessandro E., Scaltriti, Maurizio, Caporali, Andrea, D'Arca, Domenico, Scorcioni, Francesca, Astancolle, Serenella, Mangiola, Massimo, Bettuzzi, Saverio
Published 2004

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation

by Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín
Published 2006

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance

by Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar
Published in J Nucl Med (2016)

Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex

by Xie, Wei, Wang, Shengliu, Wang, Juncheng, de la Cruz, M. Jason, Xu, Guotai, Scaltriti, Maurizio, Patel, Dinshaw J.
Published in Proc Natl Acad Sci U S A (2021)

ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins

by Alcon, Clara, Zañudo, Jorge Gómez Tejeda, Albert, Reka, Wagle, Nikhil, Scaltriti, Maurizio, Letai, Anthony, Samitier, Josep, Montero, Joan
Published in Cells (2021)

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

by Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Published 2013

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

by Chandarlapaty, Sarat, Sawai, Ayana, Scaltriti, Maurizio, Rodrik-Outmezguine, Vanessa, Grbovic-Huezo, Olivera, Serra, Violeta, Majumder, Pradip K., Baselga, Jose, Rosen, Neal
Published 2011

mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling

by Rodrik-Outmezguine, Vanessa S., Chandarlapaty, Sarat, Pagano, Nen C., Poulikakos, Poulikos I., Scaltriti, Maurizio, Moskatel, Elizabeth, Baselga, José, Guichard, Sylvie, Rosen, Neal
Published 2011

Systematic functional characterization of resistance to PI3K inhibition in breast cancer

by Le, Xiuning, Antony, Rajee, Razavi, Pedram, Treacy, Daniel J., Luo, Flora, Ghandi, Mahmoud, Castel, Pau, Scaltriti, Maurizio, Baselga, Jose, Garraway, Levi A.
Published in Cancer Discov (2016)

Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

by Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea
Published in Nat Commun (2017)

Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

by Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea
Published in Nat Commun (2018)